Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
Nádia
Emi Aikawa
EA
Pediatric Rheumatology Unit, Department of Pediatrics, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Carvalho
Jozélio Freire
JF
Bonfá
Eloísa
E
Lotito
Ana Paola N
AP
Silva
Clovis Artur A
CA
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D004359:Drug Therapy, Combination; D000068800:Etanercept; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D055501:Macrophage Activation Syndrome / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D018124:Receptors, Tumor Necrosis Factor
D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept